
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Ureaplasma urealyticum epidemiology and demographics
Introduction
Overview
Overview
Genital tract colonization by Ureaplasma occur in over 40% of healthy women.[1][2][3][4] Ureaplasma species are the most common pathogen identified in VLBW infants.[4] Respiratory tract colonization by Ureaplasma is more common in preterm VLBW infants compared to term infants.[5][6] 20-45% of VLBW infants have Ureaplasma colonization of the respiratory tract.[2]
Epidemiology and Demographics
Epidemiology and Demographics
Prevalence
Ureaplasma species are commensal organisms in the female genital tract, colonizing 40-80% of the genital tract of healthy women.[1] [2][3][4] The prevalence of vaginal colonization with U. urealyticum in pregnant women is 29-42%.[7] Ureaplasma species are the most common pathogen identified in VLBW infants.[4] Ureaplasma colonization of the respiratory tract is more common in preterm VLBW infants compared to term infants.[5][6] 20-45% of VLBW infants have Ureaplasma colonization of the respiratory tract.[2] The incidence of Ureaplasma species in cord blood cultures of VLBW neonates was found to be 17%.[8] Ureaplasma species have also been shown to invade the bloodstream and cross the bloodβbrain barrier in 23% of VLBW infants in another study.[4] The prevalence of Ureaplasma positive CSF culture from preterm infants investigated for suspected meningitis was 8%.[9]
Age
Colonization by Ureaplasma species can be seen in both the pediatric and adult population. Genital tract of adult men and women are the main reservoirs of Ureaplasma species.[2][10] However, symptomatic Ureaplasma infection is seen more often in preterm neonates.[4] Colonization of neonates by U. urealyticum increases with decreasing gestational age and birth weight.[11]
Gender
There is no known gender predilection for Ureaplasma infection.
Race
A study conducted in the United States in the 1980’s in 13,747 women of low socioeconomic status from four different ethnic groups revealed that women of black ethnicity were more likely to have genital tract colonization with potentially pathogenic organisms such as U. urealyticum [12] Another study was carried out by Doh et al. in healthy pregnant women from different ethnic groups, and it revealed no racial predilection for Ureaplasma colonization.[13]
References
References
- β 1.0 1.1 Waites KB, Crouse DT, Cassell GH (1993). “Systemic neonatal infection due to Ureaplasma urealyticum”. Clin Infect Dis. 17 Suppl 1: S131β5. PMIDΒ 8399903.
- β 2.0 2.1 2.2 2.3 2.4 Resch B, Gutmann C, Reiterer F, Luxner J, Urlesberger B (2016). “Neonatal Ureaplasma urealyticum colonization increases pulmonary and cerebral morbidity despite treatment with macrolide antibiotics”. Infection. 44 (3): 323β7. doi:10.1007/s15010-015-0858-7. PMIDΒ 26518581.
- β 3.0 3.1 Okogbule-Wonodi AC, Gross GW, Sun CC, Agthe AG, Xiao L, Waites KB; et al. (2011). “Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants”. Pediatr Res. 69 (5 Pt 1): 442β7. doi:10.1203/PDR.0b013e3182111827. PMCΒ 3968774. PMIDΒ 21258263.
- β 4.0 4.1 4.2 4.3 4.4 4.5 Viscardi RM, Hashmi N, Gross GW, Sun CC, Rodriguez A, Fairchild KD (2008). “Incidence of invasive ureaplasma in VLBW infants: relationship to severe intraventricular hemorrhage”. J Perinatol. 28 (11): 759β65. doi:10.1038/jp.2008.98. PMCΒ 5334544. PMIDΒ 18596706.
- β 5.0 5.1 Waites KB, Katz B, Schelonka RL (2005). “Mycoplasmas and ureaplasmas as neonatal pathogens”. Clin Microbiol Rev. 18 (4): 757β89. doi:10.1128/CMR.18.4.757-789.2005. PMCΒ 1265909. PMIDΒ 16223956.
- β 6.0 6.1 Patterson AM, Taciak V, Lovchik J, Fox RE, Campbell AB, Viscardi RM (1998). “Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants”. Pediatr Infect Dis J. 17 (4): 321β8. PMIDΒ 9576388.
- β Vogel I, Thorsen P, Hogan VK, Schieve LA, Jacobsson B, Ferre CD (2006). “The joint effect of vaginal Ureaplasma urealyticum and bacterial vaginosis on adverse pregnancy outcomes”. Acta Obstet Gynecol Scand. 85 (7): 778β85. doi:10.1080/00016340500442423. PMIDΒ 16817073.
- β Goldenberg RL, Andrews WW, Goepfert AR, Faye-Petersen O, Cliver SP, Carlo WA; et al. (2008). “The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants”. Am J Obstet Gynecol. 198 (1): 43.e1β5. doi:10.1016/j.ajog.2007.07.033. PMCΒ 2278008. PMIDΒ 18166302.
- β Waites KB, Rudd PT, Crouse DT, Canupp KC, Nelson KG, Ramsey C; et al. (1988). “Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants”. Lancet. 1 (8575β6): 17β21. PMIDΒ 2891889.
- β Deguchi T, Yoshida T, Miyazawa T, Yasuda M, Tamaki M, Ishiko H; et al. (2004). “Association of Ureaplasma urealyticum (biovar 2) with nongonococcal urethritis”. Sex Transm Dis. 31 (3): 192β5. PMIDΒ 15076934.
- β Agarwal P, Rajadurai VS, Pradeepkumar VK, Tan KW (2000). “Ureaplasma urealyticum and its association with chronic lung disease in Asian neonates”. J Paediatr Child Health. 36 (5): 487β90. PMIDΒ 11036807.
- β Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier S, Andrews WW; et al. (1996). “Bacterial colonization of the vagina during pregnancy in four ethnic groups”. Am J Obstet Gynecol. 174 (5): 1618β1621. doi:10.1016/S0002-9378(96)70617-8. PMIDΒ 28140029.
- β Doh K, Barton PT, Korneeva I, Perni SC, Bongiovanni AM, Tuttle SL; et al. (2004). “Differential vaginal expression of interleukin-1 system cytokines in the presence of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women”. Infect Dis Obstet Gynecol. 12 (2): 79β85. doi:10.1080/10647440400003667. PMCΒ 1784593. PMIDΒ 15739821.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
